Loading clinical trials...
Loading clinical trials...
To assess safety and tolerability after treatment with LEO 134310 cutaneous solution.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
LEO Pharma
NCT06398106 · Psoriasis Vulgaris
NCT04080635 · Psoriasis Vulgaris
NCT04340076 · Psoriasis, Psoriasis Vulgaris
NCT03507946 · Psoriasis Vulgaris
NCT06191042 · Psoriasis Vulgaris, Psoriatic Arthritis
Investigational Site
Schwerin, Mecklenburg-Vorpommern
Investigational Site
Hamburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions